SCIENCE & DATA

Measure performance. Not assumed.

Ibumix is building its formulation platform through structured scientific research, generating data to validate improvements in absorption and efficiency.

The Ibumix platform is built on mechanistic understanding rather than empirical optimisation.

Improving how much of dose is actually used

The objective of Ibumix technology is to increase the proportion of an administered dose that is effectively absorbed.

This is assessed through:

  • Dissolution behaviour
  • Absorption profiles
  • Bioavailability metrics
liquid crystal drug delivery, 
self-emulsifying drug delivery system (SEDDS), 
poorly soluble drug formulation,
oral drug delivery technologies,
pharmaceutical formulation platform, 
bioavailability enhancement technologies, 
lipid-based drug delivery systems,
advanced drug delivery systems

Developed and validated in academic environment

Ibumix is advancing its research through collaboration with a UK university, providing access to controlled laboratory environments and independent scientific oversight.

This ensures that data is generated to a standard recognised by industry and future partners.


Data over assumption

Pharmaceutical development often relies on established formulation approaches.

Ibumix takes a performance-driven approach, using data to guide formulation design, optimisation, and validation.

Every iteration is measured.
Every improvement is quantified.


Structured development pathway

Steps

  • Formulation design
  • Laboratory testing
  • Data analysis
  • Optimisation
  • Validaton

From data to application

The data generated through this process supports:

  • Validation of formulation performance
  • Preparation for regulatory pathways
  • Engagement with pharmaceutical partners
  • Expansion across additional compounds